Targeting survivin to overcome docetaxel resistance in prostate cancer

被引：0
|
作者：
Peery, Robert C. [1 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4396
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nanoways to overcome docetaxel resistance in prostate cancer
    Ganju, Aditya
    Yallapu, Murali M.
    Khan, Sheema
    Behrman, Stephen W.
    Chauhan, Subhash C.
    Jaggi, Meena
    DRUG RESISTANCE UPDATES, 2014, 17 (1-2) : 13 - 23
  • [2] Targeting LIFR/c-Myc Axis to Overcome Docetaxel Resistance in Prostate Cancer
    Halder, Sushanta
    Muniyan, Sakthivel
    Chirravuri-Venkata, Ramakanth
    Nimmakayala, Rama Krishna
    Nallasamy, Palanisamy
    Nair, Hareesh B.
    Ponnusamy, Moorthy P.
    Batra, Surinder K.
    Seshacharyulu, Parthasarathy
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
    Qiu, Xiaofu
    Wang, Wei
    Li, Bijun
    Cheng, Bo
    Lin, Kangjian
    Bai, Jian
    Li, Huanhui
    Yang, Guosheng
    BMC CANCER, 2019, 19 (1)
  • [4] Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
    Xiaofu Qiu
    Wei Wang
    Bijun Li
    Bo Cheng
    Kangjian Lin
    Jian Bai
    Huanhui Li
    Guosheng Yang
    BMC Cancer, 19
  • [5] Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer
    Farah, Elia
    Zhang, Zhuangzhuang
    Utturkar, Sagar M.
    Liu, Jinpeng
    Ratliff, Timothy L.
    Liu, Xiaoqi
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 193 - 205
  • [6] Targeting MCT inhibition to overcome enzalutamide resistance in prostate cancer.
    Bhattacharjee, Sayani
    Doan, Jonathan P.
    Wynn, Rebecca
    Nadiminty, Nagalakshmi
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
    Lin, Jian-Zhong
    Wang, Zeng-Jun
    De, Wei
    Zheng, Ming
    Xu, Wei-Zhang
    Wu, Hong-Fei
    Armstrong, Alex
    Zhu, Jia-Geng
    ONCOTARGET, 2017, 8 (25) : 41064 - 41077
  • [8] Targeting of survivin to overcome cisplatin resistance in esophageal adenocarcinoma.
    Douglas, Rosalie V.
    Stevenson, Leanne
    Santos, Ralph
    Cairns, Lauren
    McCabe, Niamh H.
    Kennedy, Richard D.
    Blayney, Jaine K.
    Turkington, Richard C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer
    Chen, Lin
    Xu, Yu-Xin
    Wang, Yuan-Shuo
    Ren, Ying-Ying
    Chen, Yi-Min
    Zheng, Cheng
    Xie, Tian
    Jia, Ying-Jie
    Zhou, Jian-Liang
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 331
  • [10] Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review)
    Magadoux, L.
    Isambert, N.
    Plenchette, S.
    Jeannin, J. F.
    Laurens, V.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 919 - 928
12345